Skip to main content
. 2025 Jan 23;9(3):487–497. doi: 10.1007/s41669-025-00561-7

Table 2.

Drug and consumable acquisition payer costs

Medications Retail price (€) Co-payment Payer’s cost (€) Payer’s cost per day (€) Reference
Semaglutide 0.25 mg × 4 doses 166.54 25% 124.91 4.46 Average of the list prices of Germany and Denmark
Semaglutide 0.50 mg × 4 doses 166.54 25% 124.91 4.46
Semaglutide 1 mg × 4 doses 166.54 25% 124.91 4.46
Semaglutide 1.7 mg × 4 doses 229.28 25% 171.96 6.14
Semaglutide 2.4 mg × 4 doses 280.91 25% 210.68 7.52
Liraglutide 18 mg × 5 pens 233.66 25% 175.25 5.84 Ministerial Decree 40977 (09/24/2024) [33]
Consumable costs Reimbursed price (€) Co-payment Payer’s cost (€) Payer’s cost/needle (€)
NovoFine 32G 0.23/0.25 × 6 mm × 100 units 9.18 0% 9.18 0.092 Government Gazette (FEK B’ 4045/17-11-2017) [34]